Ident. | Authors (with country if any) | Title |
---|
000073 (2020) |
Alexander Batista-Duharte ; Luis Sendra ; Maria José Herrero ; Damiana Téllez-Martínez ; Iracilda Zeppone Carlos ; Salvador Francisco Ali O | Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement |
000077 (2020) |
Lara Šoši ; P L Kristian Selbo ; Zuzanna K. Kotkowska ; Thomas M. Kündig ; Anders H Gset ; P L Johansen | Photochemical Internalization: Light Paves Way for New Cancer Chemotherapies and Vaccines |
000079 (2020) |
Nicholas G. Economos ; Stanley Oyaghire ; Elias Quijano ; Adele S. Ricciardi ; W. Mark Saltzman ; Peter M. Glazer | Peptide Nucleic Acids and Gene Editing: Perspectives on Structure and Repair |
000120 (2020) |
Célia Faustino ; Lídia Pinheiro | Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy |
000124 (2020) |
Anna-Lena Scherr ; Adam Jassowicz ; Anna Pat ; Christin Elssner ; Lars Ismail ; Nathalie Schmitt ; Paula Hoffmeister ; Lasse Neukirch ; Georg Gdynia ; Benjamin Goeppert ; Henning Schulze-Bergkamen ; Dirk J Ger ; Bruno Christian Köhler | Knockdown of Atg7 Induces Nuclear-LC3 Dependent Apoptosis and Augments Chemotherapy in Colorectal Cancer Cells |
000166 (2020) |
Ana Luiza C. De S. L. Oliveira ; Raimundo Fernandes De Araújo Júnior [Brésil] ; Thaís Gomes De Carvalho ; Alan B. Chan ; Timo Schomann ; Filippo Tamburini ; Lioe-Fee De Geus-Oei ; Luis J. Cruz | Effect of Oxaliplatin-Loaded Poly (d,l-Lactide-co-Glycolic Acid) (PLGA) Nanoparticles Combined with Retinoic Acid and Cholesterol on Apoptosis, Drug Resistance, and Metastasis Factors of Colorectal Cancer |
000170 (2020) |
Levi Collin Nelemans ; Leonid Gurevich | Drug Delivery with Polymeric Nanocarriers—Cellular Uptake Mechanisms |
000191 (2020) |
Wenqian Wang ; Qiuyu Meng ; Qi Li ; Jinbao Liu ; Mo Zhou [République populaire de Chine] ; Zheng Jin ; Kai Zhao [République populaire de Chine] | Chitosan Derivatives and Their Application in Biomedicine |
000192 (2020) |
Ying Wu [République populaire de Chine] ; Yuexiao Tang [République populaire de Chine] ; Shangzhi Xie [République populaire de Chine] ; Xiaoxiao Zheng [République populaire de Chine] ; Shufen Zhang [République populaire de Chine] ; Jiayan Mao [République populaire de Chine] ; Baoming Wang [République populaire de Chine] ; Yuerou Hou [République populaire de Chine] ; Liqiang Hu [République populaire de Chine] ; Kequn Chai [République populaire de Chine] ; Wei Chen [République populaire de Chine] | Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer |
000232 (2020) |
Tayo Alex Adekiya ; Pierre P. D. Kondiah ; Yahya E. Choonara ; Pradeep Kumar ; Viness Pillay | A Review of Nanotechnology for Targeted Anti-schistosomal Therapy |
000288 (2019) |
Kalina Paunovska [États-Unis] ; David Loughrey [États-Unis] ; Cory D. Sago [États-Unis] ; Robert Langer [États-Unis] ; James E. Dahlman [États-Unis] | Using Large Datasets to Understand Nanotechnology |
000303 (2019) |
Yanwei Shen ; Shuting Li ; Xin Wang ; Mengying Wang ; Qi Tian ; Jiao Yang ; Jichang Wang ; Biyuan Wang ; Peijun Liu ; Jin Yang | Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin |
000319 (2019) |
Nasir Javaid ; Farzana Yasmeen ; Sangdun Choi | Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods |
000348 (2019) |
Yuanliang Yan ; Xi Chen ; Xiang Wang ; Zijin Zhao ; Wenfeng Hu ; Shuangshuang Zeng ; Jie Wei ; Xue Yang ; Long Qian ; Shuyi Zhou ; Lunquan Sun ; Zhicheng Gong ; Zhijie Xu | The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer |
000363 (2019) |
Natascha Hartl [Allemagne] ; Friederike Adams [Allemagne] ; Gabriella Costabile [Allemagne] ; Lorenz Isert [Allemagne] ; Markus Döblinger [Allemagne] ; Ximian Xiao [République populaire de Chine] ; Runhui Liu [République populaire de Chine] ; Olivia M. Merkel [Allemagne] | The Impact of Nylon-3 Copolymer Composition on the Efficiency of siRNA Delivery to Glioblastoma Cells |
000366 (2019) |
Suryaji Patil [République populaire de Chine] ; Yong-Guang Gao [République populaire de Chine] ; Xiao Lin [République populaire de Chine] ; Yu Li [République populaire de Chine] ; Kai Dang [République populaire de Chine] ; Ye Tian [République populaire de Chine] ; Wen-Juan Zhang [République populaire de Chine] ; Shan-Feng Jiang [République populaire de Chine] ; Abdul Qadir [République populaire de Chine] ; Ai-Rong Qian [République populaire de Chine] | The Development of Functional Non-Viral Vectors for Gene Delivery |
000387 (2019) |
Fang-Yu Du ; Qi-Fan Zhou ; Wen-Jiao Sun ; Guo-Liang Chen | Targeting cancer stem cells in drug discovery: Current state and future perspectives |
000399 (2019) |
Fatemeh Shafiee [Iran] ; Marc G. Aucoin [Canada] ; Ali Jahanian-Najafabadi [Iran] | Targeted Diphtheria Toxin-Based Therapy: A Review Article |
000447 (2019) |
Jingjing Song [République populaire de Chine] ; Sujie Huang [République populaire de Chine] ; Zhengzheng Zhang [République populaire de Chine] ; Bo Jia [République populaire de Chine] ; Huan Xie [République populaire de Chine] ; Ming Kai [République populaire de Chine] ; Wei Zhang [République populaire de Chine] | SPA: a peptide antagonist that acts as a cell-penetrating peptide for drug delivery |
000480 (2019) |
Jaber Emami ; Zahra Ansarypour | Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis |
000484 (2019) |
Veena Vijayan ; Adityanarayan Mohapatra ; Saji Uthaman ; In-Kyu Park | Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials |
000501 (2019) |
Chi-Feng Chiang [Taïwan] ; Yu-Hone Hsu [Taïwan] ; Chih-Chun Liu [Taïwan] ; Po-Chin Liang [Taïwan] ; Shi-Chuen Miaw [Taïwan] ; Win-Li Lin [Taïwan] | Pulsed-wave Ultrasound Hyperthermia Enhanced Nanodrug Delivery Combined with Chloroquine Exerts Effective Antitumor Response and Postpones Recurrence |
000522 (2019) |
Syahrul Sazliyana Shaharir [Malaisie] ; Mohd Shahrir Mohamed Said [Malaisie] ; Rozita Mohd [Malaisie] ; Rizna Abdul Cader [Malaisie] ; Ruslinda Mustafar [Malaisie] ; Rahana Abdul Rahman [Malaisie] | Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia |
000564 (2019) |
Oliver S. Thomas [Allemagne] ; Wilfried Weber [Allemagne] | Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet? |
000568 (2019) |
Weidong Han [République populaire de Chine] ; Binbin Xie [République populaire de Chine] ; Yiran Li [République populaire de Chine] ; Linlin Shi [République populaire de Chine] ; Jianqin Wan [République populaire de Chine] ; Xiaona Chen [République populaire de Chine] ; Hangxiang Wang [République populaire de Chine] | Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer |
000583 (2019) |
J Zsef Murányi ; Attila Varga ; Pál Gyulavári ; Kinga Pénzes ; Csilla E. Németh ; Mikl S Csala ; Lilla Peth [Hongrie] ; Antal Csámpai ; Gábor Halmos ; István Peták ; István Vályi-Nagy | Novel Crizotinib–GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems |
000601 (2019) |
Yuzhu Sun [République populaire de Chine] ; Dongmei Chen [République populaire de Chine] ; Yuanhu Pan [République populaire de Chine] ; Wei Qu [République populaire de Chine] ; Haihong Hao [République populaire de Chine] ; Xu Wang [République populaire de Chine] ; Zhenli Liu [République populaire de Chine] ; Shuyu Xie [République populaire de Chine] | Nanoparticles for antiparasitic drug delivery |
000602 (2019) |
George Mattheolabakis [États-Unis] ; Constantinos M. Mikelis [États-Unis] | Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg? |
000603 (2019) |
Magdalena Bamburowicz-Klimkowska [Pologne] ; Magdalena Poplawska [Pologne] ; Ireneusz P. Grudzinski [Pologne] | Nanocomposites as biomolecules delivery agents in nanomedicine |
000713 (2019) |
Xiangyu Sun [République populaire de Chine] ; Cheng Cheng [République populaire de Chine] ; Jinxie Zhang [République populaire de Chine] ; Xing Jin [République populaire de Chine] ; Shuqing Sun [République populaire de Chine] ; Lin Mei [République populaire de Chine] ; Laiqiang Huang [République populaire de Chine] | Intracellular Trafficking Network and Autophagy of PHBHHx Nanoparticles and their Implications for Drug Delivery |
000790 (2019) |
L. A. Dykman [Russie] ; N. G. Khlebtsov [Russie] | Gold nanoparticles in chemo-, immuno-, and combined therapy: review [Invited] |
000821 (2019) |
Sierra Walker [États-Unis] ; Sara Busatto [États-Unis] ; Anthony Pham [États-Unis] ; Ming Tian [États-Unis] ; Annie Suh [États-Unis] ; Kelsey Carson [États-Unis] ; Astrid Quintero [États-Unis] ; Maria Lafrence [États-Unis] ; Hanna Malik [États-Unis] ; Moises X. Santana [États-Unis] ; Joy Wolfram [États-Unis] | Extracellular vesicle-based drug delivery systems for cancer treatment |
000822 (2019) |
Suet Yen Chong [Singapour] ; Choon Keong Lee [Singapour] ; Chenyuan Huang [Singapour] ; Yi Hsuan Ou [Singapour] ; Christopher J. Charles [Singapour] ; Arthur Mark Richards [Singapour] ; Yub Raj Neupane [Singapour] ; Maria Vazquez Pavon [Singapour] ; Olga Zharkova [Singapour] ; Giorgia Pastorin [Singapour] ; Jiong-Wei Wang [Singapour] | Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers |
000825 (2019) |
Abi J. Vázquez-Ríos [Espagne] ; Ángela Molina-Crespo [Espagne] ; Belén L. Bouzo [Espagne] ; Rafael L Pez-L Pez [Espagne] ; Gema Moreno-Bueno [Espagne] ; María De La Fuente [Espagne] | Exosome-mimetic nanoplatforms for targeted cancer drug delivery |
000835 (2019) |
Esteban A. Orellana [États-Unis] ; Ahmed M. Abdelaal [États-Unis] ; Loganathan Rangasamy [États-Unis] ; Srinivasarao Tenneti [États-Unis] ; Sunghyun Myoung [États-Unis] ; Philip S. Low [États-Unis] ; Andrea L. Kasinski [États-Unis] | Enhancing MicroRNA Activity through Increased Endosomal Release Mediated by Nigericin |
000844 (2019) |
Tao-Tao Tang [République populaire de Chine] ; Lin-Li Lv [République populaire de Chine] ; Bin Wang [République populaire de Chine] ; Jing-Yuan Cao [République populaire de Chine] ; Ye Feng [République populaire de Chine] ; Zuo-Lin Li [République populaire de Chine] ; Min Wu [République populaire de Chine] ; Feng-Mei Wang [République populaire de Chine] ; Yi Wen [République populaire de Chine] ; Le-Ting Zhou [République populaire de Chine] ; Hai-Feng Ni [République populaire de Chine] ; Ping-Sheng Chen [République populaire de Chine] ; Ning Gu [République populaire de Chine] ; Steven D. Crowley [États-Unis] ; Bi-Cheng Liu | Employing Macrophage-Derived Microvesicle for Kidney-Targeted Delivery of Dexamethasone: An Efficient Therapeutic Strategy against Renal Inflammation and Fibrosis |
000856 (2019) |
Davide Schiroli [Royaume-Uni] ; María J. G Mara [Espagne] ; Eleonora Maurizi [Royaume-Uni] ; Sarah D. Atkinson [Royaume-Uni] ; Laura Mairs [Royaume-Uni] ; Kathleen A. Christie [Royaume-Uni] ; Diego F. Cobice [Royaume-Uni] ; Cian M. Mccrudden [Royaume-Uni] ; M. Andrew Nesbit [Royaume-Uni] ; Isabel Haro [Espagne] ; Tara Moore [Royaume-Uni] | Effective In Vivo Topical Delivery of siRNA and Gene Silencing in Intact Corneal Epithelium Using a Modified Cell-Penetrating Peptide |
000869 (2019) |
Xiaolong Huang [République populaire de Chine] ; Jun Wan [République populaire de Chine] ; Dewen Leng [République populaire de Chine] ; Yingying Zhang [République populaire de Chine] ; Shuo Yang [République populaire de Chine] | Dual-targeting nanomicelles with CD133 and CD44 aptamers for enhanced delivery of gefitinib to two populations of lung cancer-initiating cells |
000890 (2019) |
Lawrence H. Cheung [États-Unis] ; Yunli Zhao [États-Unis] ; Ana Alvarez-Cienfuegos [États-Unis] ; Khalid A. Mohamedali [États-Unis] ; Yu J. Cao [États-Unis, République populaire de Chine] ; Walter N. Hittelman [États-Unis] ; Michael G. Rosenblum [États-Unis] | Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B |
000918 (2019) |
Ivan V. Chernikov ; Valentin V. Vlassov ; Elena L. Chernolovskaya | Current Development of siRNA Bioconjugates: From Research to the Clinic |
000933 (2019) |
André Barateiro [Brésil] ; Marcelo L. M. Pereira [Brésil, Portugal] ; Sabrina Epiphanio [Brésil] ; Claudio R. F. Marinho [Brésil] | Contribution of Murine Models to the Study of Malaria During Pregnancy |
000941 (2019) |
Rima Kandil ; Yuran Xie ; Ralf Heermann ; Lorenz Isert ; Kirsten Jung ; Aditi Mehta ; Olivia M. Merkel | Coming in and Finding Out: Blending Receptor-Targeted Delivery and Efficient Endosomal Escape in a Novel Bio-Responsive siRNA Delivery System for Gene Knockdown in Pulmonary T Cells |
000946 (2019) |
Yong-Lin Lu [République populaire de Chine] ; Ya-Bin Ma [République populaire de Chine] ; Chan Feng [République populaire de Chine] ; Dong-Lei Zhu [République populaire de Chine] ; Jie Liu [République populaire de Chine] ; Lv Chen [République populaire de Chine] ; Shu-Jing Liang [République populaire de Chine] ; Chun-Yan Dong [République populaire de Chine] | Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression |
000947 (2019) |
Liu-Qing Yang [République populaire de Chine] ; Ru-Yi Li [République populaire de Chine] ; Xi-Yan Yang [République populaire de Chine] ; Qian-Fei Cui [République populaire de Chine] ; Fei-Yun Wang [République populaire de Chine] ; Guo-Qiang Lin [République populaire de Chine] ; Jian-Ge Zhang [République populaire de Chine] | Co-administration of Shexiang Baoxin Pill and Chemotherapy Drugs Potentiated Cancer Therapy by Vascular-Promoting Strategy |
000948 (2019) |
Jie Gao [République populaire de Chine] ; Junjie Liu [République populaire de Chine] ; Fangyuan Xie [République populaire de Chine] ; Ying Lu [République populaire de Chine] ; Chuan Yin [République populaire de Chine] ; Xian Shen [République populaire de Chine] | Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles |
000961 (2019) |
Kamil Rahme ; Nazih Dagher | Chemistry Routes for Copolymer Synthesis Containing PEG for Targeting, Imaging, and Drug Delivery Purposes |
000978 (2019) |
Wangta Liu [Taïwan] ; Yu-Lun Lo [Taïwan] ; Chin Hsu [Taïwan] ; Yi-Ting Wu [Taïwan] ; Zi-Xian Liao [Taïwan] ; Wen-Jeng Wu [Taïwan] ; Yi-Jou Chen [Taïwan] ; Chieh Kao [Taïwan] ; Chien-Chih Chiu [Taïwan] ; Li-Fang Wang [Taïwan] | CS-PEI/Beclin-siRNA Downregulate Multidrug Resistance Proteins and Increase Paclitaxel Therapeutic Efficacy against NSCLC |
000991 (2019) |
Sean Joyce ; Adel M. Nour | Blocking transmembrane219 protein signaling inhibits autophagy and restores normal cell death |
000A45 (2019) |
Shima Tavakol ; Milad Ashrafizadeh ; Shuo Deng ; Maryam Azarian [Espagne] ; Asghar Abdoli ; Mahsa Motavaf ; Delaram Poormoghadam ; Hashem Khanbabaei ; Elham Ghasemipour Afshar ; Ali Mandegary ; Abbas Pardakhty ; Celestial T. Yap ; Reza Mohammadinejad [Iran] ; Alan Prem Kumar [Singapour] | Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems |
000A66 (2019) |
Ana Paula Dinis Ano Bom ; Patrícia Cristina Da Costa Neves ; Carlos Eduardo Bonacossa De Almeida ; Dilson Silva ; Sotiris Missailidis | Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer |
000A74 (2019) |
Jeremie Rossier ; Sara Nasiri Sovari ; Aleksandar Pavic ; Sandra Vojnovic ; Tameryn Stringer ; Sarah B Ttig ; Gregory S. Smith ; Jasmina Nikodinovic-Runic ; Fabio Zobi | Antiplasmodial Activity and In Vivo Bio-Distribution of Chloroquine Molecules Released with a 4-(4-Ethynylphenyl)-Triazole Moiety from Organometallo-Cobalamins |